OFSA3 Stock Overview
Engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Ouro Fino Saúde Animal Participações S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$19.00 |
| 52 Week High | R$27.72 |
| 52 Week Low | R$18.50 |
| Beta | 1.05 |
| 1 Month Change | -14.07% |
| 3 Month Change | -11.83% |
| 1 Year Change | -23.05% |
| 3 Year Change | -24.54% |
| 5 Year Change | -55.87% |
| Change since IPO | -31.28% |
Recent News & Updates
Recent updates
We Think Ouro Fino Saúde Animal Participações' (BVMF:OFSA3) Healthy Earnings Might Be Conservative
Aug 15
One Ouro Fino Saúde Animal Participações S.A. (BVMF:OFSA3) Analyst Just Cut Their EPS Forecasts
May 19Is Ouro Fino Saúde Animal Participações (BVMF:OFSA3) A Risky Investment?
Dec 20These 4 Measures Indicate That Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Is Using Debt Reasonably Well
Jul 28We Think Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Can Stay On Top Of Its Debt
Feb 01Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Has A Pretty Healthy Balance Sheet
May 27Is Now The Time To Put Ouro Fino Saúde Animal Participações (BVMF:OFSA3) On Your Watchlist?
Mar 01Does Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Have A Healthy Balance Sheet?
Feb 08Ouro Fino Saúde Animal Participações S.A.'s (BVMF:OFSA3) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Jan 21Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Is Growing Earnings But Are They A Good Guide?
Jan 03
Introducing Ouro Fino Saúde Animal Participações (BVMF:OFSA3), A Stock That Climbed 42% In The Last Three Years
Dec 15Should You Be Adding Ouro Fino Saúde Animal Participações (BVMF:OFSA3) To Your Watchlist Today?
Nov 27What You Can Learn From Ouro Fino Saúde Animal Participações S.A.'s (BVMF:OFSA3) P/E
Aug 09We Think Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Is Taking Some Risk With Its Debt
Jul 13Shareholder Returns
| OFSA3 | BR Pharmaceuticals | BR Market | |
|---|---|---|---|
| 7D | -10.8% | -8.4% | -7.2% |
| 1Y | -23.0% | -28.7% | -11.5% |
Return vs Industry: OFSA3 exceeded the BR Pharmaceuticals industry which returned -27.3% over the past year.
Return vs Market: OFSA3 underperformed the BR Market which returned -9.2% over the past year.
Price Volatility
| OFSA3 volatility | |
|---|---|
| OFSA3 Average Weekly Movement | 4.6% |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in BR Market | 9.2% |
| 10% least volatile stocks in BR Market | 2.7% |
Stable Share Price: OFSA3 has not had significant price volatility in the past 3 months compared to the BR market.
Volatility Over Time: OFSA3's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 1,202 | Kleber Cesar Gomes | www.ourofinosaudeanimal.com |
Ouro Fino Saúde Animal Participações S.A., together with its subsidiaries, engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil. The company operates through three segments: Production Animals, Companion Animals, and International Operations. It manufactures and trades in medicines, including anti-inflammatories, antibiotics, anticoccidials, antimastitics, ectoparasiticides, endectocides, endoparasiticides, hemoparasiticides, inoculants, therapeutics, products for animal reproduction, and vaccines; and performance-enhancing additives, probiotics, and other veterinary products for cattle, swine, poultry, sheep, horses, and goats, as well as manufacturing services.
Ouro Fino Saúde Animal Participações S.A. Fundamentals Summary
| OFSA3 fundamental statistics | |
|---|---|
| Market cap | R$1.11b |
| Earnings (TTM) | R$91.06m |
| Revenue (TTM) | R$958.76m |
11.2x
P/E Ratio1.1x
P/S RatioIs OFSA3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OFSA3 income statement (TTM) | |
|---|---|
| Revenue | R$958.76m |
| Cost of Revenue | R$493.73m |
| Gross Profit | R$465.02m |
| Other Expenses | R$373.96m |
| Earnings | R$91.06m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 13, 2025
| Earnings per share (EPS) | 1.69 |
| Gross Margin | 48.50% |
| Net Profit Margin | 9.50% |
| Debt/Equity Ratio | 49.2% |
How did OFSA3 perform over the long term?
See historical performance and comparisonDividends
3.5%
Current Dividend Yield20%
Payout RatioDoes OFSA3 pay a reliable dividends?
See OFSA3 dividend history and benchmarks| Ouro Fino Saúde Animal Participações dividend dates | |
|---|---|
| Ex Dividend Date | Jan 02 2025 |
| Dividend Pay Date | Jan 10 2025 |
| Days until Ex dividend | 14 days |
| Days until Dividend pay date | 22 days |
Does OFSA3 pay a reliable dividends?
See OFSA3 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 07:39 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ouro Fino Saúde Animal Participações S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|